Page 1 of Clinical Trials for Single dose psoriasis study, 122 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects
Last Updated: July 5, 2011
Condition(s): Plaque Psoriasis
2
Withdrawn
Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.
Last Updated: October 19, 2011
Condition(s): Moderate to Severe Plaque Psoriasis
3
Completed
Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis
Last Updated: August 19, 2010
Condition(s): Psoriasis
4
Completed
Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis
Last Updated: March 2, 2011
Condition(s): Chronic Plaque Psoriasis
5
Completed
A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545
Last Updated: November 16, 2011
Condition(s): Chronic Plaque Psoriasis
6
Recruiting
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis
Last Updated: January 12, 2012
Condition(s): Psoriasis
7
Completed
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of AbGn-168 in Psoriasis
Last Updated: June 1, 2011
Condition(s): Psoriasis
8
Completed
A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis
Last Updated: December 12, 2008
Condition(s): Plaque Psoriasis
9
Completed
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis
Last Updated: September 29, 2011
Condition(s): Psoriasis
10
Recruiting
A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis
Last Updated: December 6, 2011
Condition(s): Psoriasis
11
Recruiting
A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)
Last Updated: May 18, 2012
Condition(s): Psoriasis
12
Terminated
First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals of Biologic and Clinical Effects
Last Updated: February 2, 2011
Condition(s): Psoriasis; Inflammation
13
Completed
Micellar Paclitaxel to Treat Severe Psoriasis
Last Updated: March 3, 2008
Condition(s): Psoriasis
14
Completed
A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris
Last Updated: April 11, 2011
Condition(s): Psoriasis Vulgaris
15
Completed
A Study of the Safety and Efficacy of CNTO 1275 in Subjects With Severe Plaque-Type Psoriasis
Last Updated: May 14, 2009
Condition(s): Psoriasis
16
Completed
A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015K
Last Updated: December 2, 2011
Condition(s): Bioavailability of ASP015K; Pharmacokinetics of ASP015K; Healthy Subjects
17
Completed
LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects
Last Updated: May 7, 2010
Condition(s): Psoriasis Vulgaris
18
Completed
A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New Formulation
Last Updated: December 1, 2011
Condition(s): Pharmacokinetics of ASP015K; Bioavailability of ASP015K; Healthy Subjects
19
Completed
The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)
Last Updated: August 1, 2011
Condition(s): Psoriasis
20
Recruiting
Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis
Last Updated: February 24, 2012
Condition(s): Psoriasis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Single+dose+psoriasis+study

Page 1 of Clinical Trials for Single dose psoriasis study, 122 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About